ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Ophthalmology

Top Ophthalmology Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID BERRY MD

Ophthalmology

6,569

$428K

662
580 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 61%

$65
Average prescription price

Avg: $75

BRIAN WELCOME M.D.

Ophthalmology

6,330

$522K

712
633 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 61%

$83
Average prescription price

Avg: $75

SAMUEL SELTZER MD

Ophthalmology

6,001

$298K

1186
1030 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 61%

$50
Average prescription price

Avg: $75

DOUGLAS STOKES M.D.

Ophthalmology

5,906

$421K

889
809 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

54%
prescriptions for brand name drugs

Avg: 61%

$71
Average prescription price

Avg: $75

ISAM ZAKHOUR M.D.

Ophthalmology

5,084

$324K

818
714 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 61%

$64
Average prescription price

Avg: $75

DANIEL FLEMING M.D.

Ophthalmology

4,826

$264K

706
643 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 61%

$55
Average prescription price

Avg: $75

HOWARD GREENE M.D.

Ophthalmology

4,556

$285K

647
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 61%

$62
Average prescription price

Avg: $75

ALEXANDER KENT M.D.

Ophthalmology

4,481

$278K

431
372 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 61%

$62
Average prescription price

Avg: $75

JOHN HAZELTON M.D.

Ophthalmology

4,445

$302K

888
804 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 61%

$68
Average prescription price

Avg: $75

SAMUEL MONTGOMERY M.D.

Ophthalmology

4,437

$395K

1060
883 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 61%

$89
Average prescription price

Avg: $75

SHAWN RILEY MD

Ophthalmology

4,363

$456K

707
646 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 61%

$105
Average prescription price

Avg: $75

HARVARD RIDDLE M.D.

Ophthalmology

4,129

$271K

931
793 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 61%

$66
Average prescription price

Avg: $75

MARK WOLKEN M.D.

Ophthalmology

3,821

$234K

714
619 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 61%

$61
Average prescription price

Avg: $75

DAOLING ZHANG MD

Ophthalmology

3,586

$198K

575
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 61%

$55
Average prescription price

Avg: $75

MARK ROSS M.D.

Ophthalmology

3,433

$242K

666
543 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 61%

$71
Average prescription price

Avg: $75

MATTHEW NUTAITIS M.D.

Ophthalmology

3,389

$240K

476
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 61%

$71
Average prescription price

Avg: $75

ALAN LEAHEY MD

Ophthalmology

3,331

$340K

614
570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 61%

$102
Average prescription price

Avg: $75

GREGORY KING M.D.

Ophthalmology

3,047

$218K

490
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 61%

$72
Average prescription price

Avg: $75

BILLY HAGUEWOOD M.D.

Ophthalmology

2,887

$195K

679
587 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 61%

$68
Average prescription price

Avg: $75

BRICE DILLE M.D.

Ophthalmology

2,877

$189K

628
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 61%

$66
Average prescription price

Avg: $75

HUNTER STOKES M.D.

Ophthalmology

2,844

$214K

533
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

68%
prescriptions for brand name drugs

Avg: 61%

$75
Average prescription price

Avg: $75

DEMETRAJANE KOKINAKIS DO

Ophthalmology

2,798

$254K

520
430 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 61%

$91
Average prescription price

Avg: $75

WILLIAM BALLINGER M.D.

Ophthalmology

2,750

$175K

567
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 61%

$64
Average prescription price

Avg: $75

FULTON GASPER MD

Ophthalmology

2,696

$167K

591
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 61%

$62
Average prescription price

Avg: $75

JAMES GOODSON M.D.

Ophthalmology

2,673

$201K

537
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 61%

$75
Average prescription price

Avg: $75

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank